{
    "title": "Drug-Receptor Interactions",
    "type": "dcq",
    "author": "ayobami",
    "course": "pharmacology",
    "date": "2024-09-03 09:00",
    "description": "examining the pharmacokinetics of how drugs target receptors to mediate their effects",
    "difficulty": "medium",
    "questions": [
        {
            "question": "Binding of agonists causes the equilibrium to shift from active(R*) to inactive(R) form to produce a biologic effect",
            "answer": "false"
        },
        {
            "question": "Binding of antagonists causes the equilibrium to shift from inactive(R) to active(R*) form to produce a biologic effect",
            "answer": "false"
        },
        {
            "question": "Binding of agonists causes the equilibrium to shift from inactive (R*) to active(R) form to produce a biologic effect",
            "answer": "false"
        },
        {
            "question": "Binding of antagonists to a receptor stabilize the active (R*) form",
            "answer": "false"
        },
        {
            "question": "Binding of antagonists to a receptor stabilize the inactive (R*) form",
            "answer": "false"
        },
        {
            "question": "Binding of antagonists to a receptor stabilize the inactive (R) form",
            "answer": "true"
        },
        {
            "question": "The ùõÉ-adrenegic receptor uses cAMP as its second-messanger",
            "answer": "true"
        },
        {
            "question": "The ùõÇ1-adrenegic receptor uses phosphatinositides as its second messangers",
            "answer": "true"
        },
        {
            "question": "The GABA A- receptor uses cAMP as its second-messanger",
            "answer": "false"
        },
        {
            "question": "The GABA A- is a ligand-gated channel that increases chloride influx, resulting in depolarization of neurons, and more chance of generating an action potential",
            "answer": "false"
        },
        {
            "question": "The GABA A- is a ligand-gated channel that increases chloride influx, resulting in hyperpolarization of neurons, and less chance of generating an action potential",
            "answer": "true"
        },
        {
            "question": "A system in which only a fraction of the total receptors have to be occupied to produce a maximal response is said to have spare receptors",
            "answer": "true"
        },
        {
            "question": "The ùõÉ-adrenoceptors in the heart have a large functional reserve because they have 5-10% of spare receptors",
            "answer": "false"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(A) is inhibited by digoxin",
            "answer": "true"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(A) is inhibited by digoxin",
            "answer": "true"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(A) is inhibited by digoxin",
            "answer": "true"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(A) is inhibited by paclitaxel",
            "answer": "false"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(A) is inhibited by aspirin",
            "answer": "false"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(C) is inhibited by NSAIDs",
            "answer": "true"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(C) is inhibited by aspirin",
            "answer": "true"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(D) is inhibited by anti-parkinson's drugs",
            "answer": "true"
        },
        {
            "text": "Na/K ATPase (A), Monoamine Oxidase A (B), Cyclooxygenase (C), Monoamine Oxidase B (D)",
            "question": "(D) is inhibited by antidepressants",
            "answer": "false"
        },
        {
            "question": "In drug tolerance, repeated exposure of a receptor to an agonist, results in upregulation of receptors",
            "answer": "false"
        },
        {
            "question": "In drug tolerance, repeated exposure of a receptor to an antagonist, results in upregulation of receptors",
            "answer": "true"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "Nicotinic receptor is an example of (A)",
            "answer": "true"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "Insulin receptor is an example of (B)",
            "answer": "false"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "Insulin receptor is an example of (D)",
            "answer": "true"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "A- subtype of ùõÑ-aminobutyric acid receptor is an example of (A)",
            "answer": "true"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "ùõÉ-adrenegic receptor is an example of (C) that uses cAMP",
            "answer": "true"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "ùõÉ-adrenegic receptor is an example of (C) that uses phosphoinositides",
            "answer": "false"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "ùõÇ1-adrenegic receptor is an example of (C) that uses cAMP",
            "answer": "false"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "Sodium channel is an example of (B)",
            "answer": "true"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "Epidermal Growth Factor Receptor is an example of (C)",
            "answer": "false"
        },
        {
            "text": "Ligand-gated channels (A), Voltage-gated channels (B), G-Protein Coupled Receptors (C), Nuclear Receptors (D)",
            "question": "Epidermal Growth Factor Receptor is an example of (C)",
            "answer": "false"
        }
    ]
}
